Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales.

Gibson R, MacLeod N, Donaldson LJ, et al. A mixed‐methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community‐based care in England and Wales. Addiction. 2020;115(11):2066-2076. doi:10.1111/add.15039.

Save
Print
November 11, 2020
Gibson R, MacLeod N, Donaldson LJ, et al. Addiction. 2020;115(11):2066-2076.
View more articles from the same authors.

Methadone and buprenorphine are commonly prescribed to treat opioid use disorder, but their use presents patient safety risks. Using national data from England and Wales, this study analyzed 2,284 patient safety incident reports and found that harmful incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care stemmed from errors in dispensing practices (e.g. wrong patient, incorrect dose, incorrect formulation). Staff- and organization-related factors – such as not following protocols, poor continuity of care – contributed to more than half of the incidents.

Save
Print
Cite
Citation

Gibson R, MacLeod N, Donaldson LJ, et al. A mixed‐methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community‐based care in England and Wales. Addiction. 2020;115(11):2066-2076. doi:10.1111/add.15039.